GSP Crop Science Ltd

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

GSP Crop Science Ltd trades at ₹498, in a confirmed uptrend and 25 weeks into that stage. That is +9.1% against its own 200-day average. It sits at 45% of a 52-week range of ₹394 to ₹627. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 11 straight weeks.

Today the stock is in a confirmed uptrend — week 25 of stage 2, confirmed. At ₹498 it trades +9.1% versus its 200-day average and sits at 45% of its 52-week range (₹394–₹627).

Against the market, two honest reads. Cumulative: over the last 5 months the stock moved +18% while the NIFTY 500 moved −2% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 11 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

GSP Crop Science Ltd trades at 22.2× P/E, at the pricey end of its own range (77th percentile). Its long-run median P/E is 19.5×, measured across 0.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 22.2× is at the pricey end of its own range (77th percentile), against a long-run median of 19.5× measured over 0.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

GSP Crop Science Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 4 quarters across 1 curve, on partial evidence.

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

4-Factor Sector Score

47.2/100 — rank 18 of 18 in Pesticides/Agrochemicals · 38% evidence confidence · provisional, ranked below fully-evidenced peers

GSP Crop Science Ltd scores 47.2 out of 100 against the 18 companies it is compared with in Pesticides/Agrochemicals, ranking 18. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

The four contributions add to the total exactly: 14.8 + 12.7 + 9.7 + 10 = 47.2. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

Revenue Revenue is the top line: everything the company billed its customers in the period.

GSP Crop Science Ltd reported ₹386 Cr of revenue in the Jun 26 quarter, +2.4% year on year. That is the 2nd straight quarter of year-on-year growth. Over 6 years it has compounded at 9.0% a year. The last full year, FY26, came in at ₹1,517 Cr. The last four reported quarters add to ₹1,525 Cr.

FY26 revenue came in at ₹1,517 Cr (+17.9% on the year), capping 6 years at 9.0% compound. The latest quarter (Jun 26) printed ₹386 Cr, +2.4% year on year — the 2nd consecutive quarter of year-over-year growth.

Pace check: the last four quarters averaged +10.2% growth against the decade's 9.0% — the current year is running faster than its own long-run rate.

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

GSP Crop Science Ltd's operating margin is 11.0% in the Jun 26 quarter, +0.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 7 fiscal years the operating margin has ranged 7.0% to 12.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 11.0%, +0.0 pp against the same quarter a year ago. Across 7 fiscal years the operating margin has ranged 7.0%–12.0%, and FY26's 12.0% is the top of that band — a record year.

🚨 Why the margin moved: operating margin went −0.2 pp year on year while gross margin went +2.4 pp — the loss came mostly from the gross line: input costs and pricing.

Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

GSP Crop Science Ltd earned ₹26.0 Cr of net profit in the Jun 26 quarter, +13.0% year on year. Full-year FY26 profit was ₹95.0 Cr. The 6-year compound rate is 28.6%. That is 6.7% of the quarter's revenue. The same quarter a year earlier earned ₹23.0 Cr.

Jun 26 profit was ₹26.0 Cr, +13.0% year on year. On the full year, FY26 printed ₹95.0 Cr (+15.9%), and the 6-year compound rate is 28.6%.

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 128% of GSP Crop Science Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹59.0 Cr of operating cash against ₹95.0 Cr of profit. After ₹61.0 Cr of capital spending, ₹−2.0 Cr was left as free cash.

FY26: operating cash of ₹59.0 Cr against reported profit of ₹95.0 Cr, leaving free cash of ₹−2.0 Cr after ₹61.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 128% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

Why conversion sits at 128%: the cash cycle stretched 31 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.

Router verdict: the bigger cash user is investment — capital spending ran 2.5× depreciation over three years, so the next section's job is to check what that build-out is buying.

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

GSP Crop Science Ltd's cash conversion cycle runs 121 days in FY26, up from 90 days in FY21. Capital spending ran ₹183 Cr over the last 3 years. At FY26 sales of ₹1,517 Cr each day of that cycle holds about ₹4.2 Cr, so roughly ₹503 Cr sits inside the business at any moment.

FY26: debtors at 133 days, inventory at 146 days — roughly 4.8 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 121 days, looser than FY21's 90.

The full loop: cash goes out to suppliers and production on day 0; stock waits 146 days to sell; customers pay about 133 days after that; and suppliers themselves are paid at 158 days — netting out to the 121-day cycle.

In money terms: at FY26 sales of ₹1,517 Cr, each day of the cycle holds about ₹4.2 Cr — so the 121-day loop keeps roughly ₹503 Cr sitting inside the business at any moment.

On the investment side: capital spending of ₹183 Cr over the last 3 fiscal years against ₹73.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹67.0 Cr (FY26) — capacity paid for but not yet earning.

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

GSP Crop Science Ltd earns a ROCE of 19% in FY26. That is up from a trough of 8% in FY23. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 6.3% net margin on 0.98× asset turns.

FY26 ROCE is 19%, recovered from a FY23 trough of 8% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY26): 6.3% net margin × 0.98× asset turns × 2.00× balance-sheet leverage ≈ 12.3% on equity. Margin does its share; leverage is a meaningful part of the equation.

The quarterly return curves and the return-on-invested-capital overlay, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 74% on reported income across 6 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.

GSP Crop Science Ltd carries ₹262 Cr of borrowings against ₹772 Cr of equity in FY26, a debt-to-equity of 0.34. Operating profit covers the interest bill 5×. Over 5 years borrowings went from ₹139 Cr to ₹262 Cr. Capital spending ran ₹183 Cr across the last 3 of those years.

FY26: borrowings of ₹262 Cr against equity of ₹772 Cr — a debt-to-equity of 0.34. Operating profit covers the interest bill 5×. Over 5 years borrowings went from ₹139 Cr to ₹262 Cr while capital spending ran ₹183 Cr in just the last 3 — part of the build-out is riding on borrowed money.

The total-debt and debt-to-equity series, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 74% on reported income across 6 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

No holder of GSP Crop Science Ltd moved a full percentage point over the last two years — the register is quiet. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — .

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

GSP Crop Science Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

Frequently asked questions